Depression |
Depression/depressive Disorders |
Clinical Trial: Group Therapy for Postpartum Depression
This study is currently recruiting patients.
|
Purpose
The purpose of this study is to examine the efficacy of a mother-infant relational group therapy approach for postpartum depression by comparing it to a standard individual treatment approach.
| Condition | Treatment or Intervention |
|---|---|
| Depression, Postpartum | Behavior: Mother-Infant Psychotherapy Behavior: Interpersonal Psychotherapy |
MedlinePlus related topics: Postpartum Depression
Study Type: Interventional
Study Design: Treatment, Randomized, Single Blind, Active Control, Parallel Assignment, Efficacy Study
Official Title: Relational Group Intervention for Postpartum Depression
Expected Total Enrollment: 208
Study start: January 2002
Ten to twenty percent of new mothers experience major depression in the postpartum period or postpartum depression (PPD). This condition poses a risk for disturbances in the mother-infant relationship as well as for developmental delays and subsequent psychopathology in their children. Thus, and investigation of the efficacy of a relational approach that focuses on improving the mother's sense of competence in the parenting role, and reducing depressive symptoms and social isolation through group therapy is warranted.
Patients are randomly assigned to either relational group treatment or to standard individual treatment. Assessments of maternal and infant functioning, mother-infant and father-infant relations, parenting stress, and marital conflict and conducted pre- and post-treatment, at 12 months post-treatment, and when infants are 12 and 24 months of age.
Eligibility
Ages Eligible for Study: 18 Years and above, Genders Eligible for Study: Female
Criteria
Inclusion Criteria:
- Major depression with an infant under 7 months of age
Exclusion Criteria:
- Bipolar disorder
- Schizophrenia
- Organic brain syndrome
- Antisocial personality disorder
- Current psychosis or mania
- Lifetime history of mental retardation
- Current alcohol or substance abuse
- Cognitive disability
- Infants born more than 6 weeks premature or with major medical conditions or developmental disabilities
Location and Contact Information
Wisconsin
Univ. of Wisconsin Dept. of Psychiatry, Madison, Wisconsin, 53719, United States; Recruiting
Kathleen Hipke, PhD 608-263-6123 khipke@wisc.edu
More Information
Record last reviewed: January 2005
Last Updated: January 12, 2005
Record first received: January 7, 2003
ClinicalTrials.gov Identifier: NCT00051246
Health Authority: United States: Federal Government
ClinicalTrials.gov processed this record on 2005-04-08
Source: ClinicalTrials.gov
Cache Date: April 9, 2005

Not Signed In -


